货号:A236736
                
                同义名:
                    
                        
                            
                                BMX kinase inhibitor; BMX Inhibitor 1
                            
                        
                    
                
                
                
                    
                    
                
            
BMX-IN-1是一种选择性的、不可逆的骨髓酪氨酸激酶X染色体(BMX)抑制剂,靶向BMX ATP结合区的Cys496,IC50为8 nM。
                                
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} | 
                                     {[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | 
                                
                                     {[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | 
                                {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
                        
                    
| 产品名称 | BTK ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CGI-1746 | 
                                                
                                                    +++
                                                    
                                                    
                                                     BTK, IC50: 1.9 nM  | 
                                            
                                        
                                        98% | |||||||||||||||||
| Spebrutinib | 
                                                
                                                    ++++
                                                    
                                                    
                                                     BTK, IC50: <0.5 nM  | 
                                            
                                        
                                        98+% | |||||||||||||||||
| Acalabrutinib | 
                                                
                                                    ++
                                                    
                                                    
                                                     BTK, IC50: 3nM  | 
                                            
                                        
                                        98% | |||||||||||||||||
| CNX-774 | 
                                                
                                                    +++
                                                    
                                                    
                                                     BTK, IC50: <1 nM  | 
                                            
                                        
                                        99%+ | |||||||||||||||||
| Ibrutinib | 
                                                
                                                    ++++
                                                    
                                                    
                                                     BTK, IC50: 0.5 nM  | 
                                            
                                        
                                        98% | |||||||||||||||||
| ONO-4059 analog | 
                                                
                                                    +
                                                    
                                                    
                                                     BTK, IC50: 23.9 nM  | 
                                            
                                        
                                        98% | |||||||||||||||||
| RN486 | 
                                                
                                                    ++
                                                    
                                                    
                                                     BTK, IC50: 4 nM  | 
                                            
                                        
                                        99%+ | |||||||||||||||||
| (Z)-LFM-A13 | 
                                                
                                                    +
                                                    
                                                    
                                                     BTK, Ki: 1.4 μM  | 
                                            
                                        
                                        99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with IC50 of 8 nM | 
| Concentration | Treated Time | Description | References | |
| SiHa cells | 13 µM | 30-60 min | Inhibited BMX expression, significantly decreased cell proliferation | Oncotarget. 2017 Jul 25;8(30):49238-49252 | 
| CWR22Rv1 cells | 5 μM | 72 h | To evaluate the inhibitory effect of BMX-IN-1 on the proliferation of CWR22Rv1 cells, results showed that BMX-IN-1 significantly inhibited cell proliferation. | Cancer Res. 2018 Sep 15;78(18):5203-5215 | 
| Administration | Dosage | Frequency | Description | References | ||
| ICR SCID mice | Prostate cancer xenograft model | Intraperitoneal injection | 50 or 100 mg/kg | Once daily, duration not specified | To evaluate the inhibitory effect of BMX-IN-1 on tumor growth in a prostate cancer xenograft model, results showed that BMX-IN-1 significantly suppressed tumor growth. | Cancer Res. 2018 Sep 15;78(18):5203-5215 | 
| 计算器 | ||||
| 存储液制备 | ![]()  | 
                        1mg | 5mg | 10mg | 
| 
                             1 mM 5 mM 10 mM  | 
                        
                             1.91mL 0.38mL 0.19mL  | 
                        
                             9.53mL 1.91mL 0.95mL  | 
                        
                             19.06mL 3.81mL 1.91mL  | 
                    |
| CAS号 | 1431525-23-3 | 
| 分子式 | C29H24N4O4S | 
| 分子量 | 524.59 | 
| SMILES Code | O=C1N(C2=C(C=C1)C=NC3=CC=C(C4=CC=C(NS(=O)(C)=O)C=C4)C=C32)C5=CC=C(C)C(NC(C=C)=O)=C5 | 
| MDL No. | MFCD25372042 | 
| 别名 | BMX kinase inhibitor; BMX Inhibitor 1 | 
| 运输 | 蓝冰 | 
| 存储条件 | 
                                
                                    
                                             In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, room temperature  | 
                        
| 溶解方案 | 
                                
                                    
                                     DMSO: 7 mg/mL(13.34 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO DMF: 10 mg/mL(19.06 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
  | 
                        
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1